Bringing more life-saving innovations and transformative research from
An expert in commercialization of university scholarship and technology, Prestwich will work with WSU faculty, students and administrators on the
"Technology transfer is an important outcome of much of the research occurring at WSU, especially our work in the biomedical arena," said WSU Spokane Chancellor
"His broad experience and leadership as an outstanding faculty researcher and a successful inventor and entrepreneur will strengthen and expand the impact of WSU's commitment to economic development throughout
Prestwich will have offices on both the WSU Spokane and
Prestwich is the presidential professor of medicinal chemistry and the director of the Entrepreneurial Faculty Scholars Program at the
He is a fellow of the
"I am excited about the vast potential I see at WSU," Prestwich said. "The number and quality of research faculty and graduate students at the university suggest great potential to generate ideas for commercial products and to see them delivered into the public good."
Prestwich will work to build new partnerships inside and outside the university and to strengthen existing university collaborations with business and industry. He will provide advice and consulting for WSU faculty, students and staff to advance external applications of their research.
A resident of
Prestwich's startups include Echelon Biosciences for lipid signaling reagents in cell biology, Sentrx Animal Care for hydrogels for cutaneous and ocular wound repair in large and small animals, Glycosan for human clinical cell therapy matrices, and GlycoMira for inflammation modulating therapies for periodontal disease and bladder inflammation. He also is a scientific advisor to
He is a 2006 recipient of the
In 2010, Prestwich received the
Prestwich holds a doctorate in organic chemistry from
Patents from his university research include inventions in the following areas:
* new compounds for lipid signaling in cell biology and cancer treatment
* biomaterials for wound repair, cartilage repair, tissue engineering, scar-free healing, and toxicology and xenograft models
* inflammation modulators for clinical use.
TNS 30TagarumaMar-140618-4770055 30TagarumaMar
Most Popular Stories
- National Retail Federation Reduces Sales Forecast
- Hispanic Leader Goes the Extra Mile
- Xavier Gutierrez Appointed to Bank Board
- Ted Cruz: Why Did FAA Ban Flights to Israel?
- Honda' s Accord Plug-in Hybrid Is a Fuel Miser
- Morgan Stanley Ponies Up $275 Million to Settle SEC Charges
- Stop-Start Engines Save Gas, Reduce Emissions
- Long-term Strengths Emerge in U.S. Economy
- Risks of Layoffs Becoming Rarer in U.S.
- Weekly Jobless Claims Drop to Lowest Level in 8 Years